Status:
RECRUITING
Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry
Lead Sponsor:
University of California, Los Angeles
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
11-15 years
Phase:
NA
Brief Summary
Objective: Posttraumatic stress disorder (PTSD) is a prevalent neuropsychiatric disorder in children and is associated with increased neurovascular inflammation, suicidality, adulthood mental health d...
Eligibility Criteria
Inclusion
- Boy/Girl with documented PTSD,
- aged 11- 15 years old,
- able to read/write in English
Exclusion
- presence of intellectual disabilities,
- presence of psychotic or self-injurious behavior,
- presence of seizure disorder,
- presence of language disorder,
- presence of eye disorders,
- presence of other neurodevelopmental disorders,
- presence of diagnosis of substance use disorder.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 28 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04529031
Start Date
September 1 2024
End Date
December 28 2026
Last Update
January 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90024